HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Valcour, Victor G ^a,b   Ananworanich, Jintanat ^c,d,e,f   Agsalda, Melissa ^f   Sailasuta, Napapon ^g   Chalermchai, Thep ^c   Schuetz, Alexandra ^h   Shikuma, Cecilia ^f   Liang, Chin Yuan ^f   Jirajariyavej, Supunee ⁱ   Sithinamsuwan, Pasiri ^j   Tipsuk, Somporn ^c   Clifford, David B ^k   Paul, Robert ^l   Fletcher, James L K ^c   Marovich, Mary A ^m,n   Slike, Bonnie M ^n,o   DeGruttola, Victor ^c   Shiramizu, Bruce ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f UNIVERSITY OF HAWAII   (United States)

^g HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^h ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

ⁱ Taksin Hospital   (Thailand)

^j PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o Queen Savang Vadhana Memorial Hospital   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INOSITOL; N ACETYLASPARTIC ACID; NEOPTERIN; VIRUS DNA; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BRAIN INJURY; CD4 LYMPHOCYTE COUNT; COMBINATION ANTIRETROVIRAL THERAPY; DISEASE ASSOCIATION; FEMALE; GLIA; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; ANTIGENS, CD14; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN; COGNITION DISORDERS; CYTOKINES; DNA, VIRAL; FEMALE; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MONOCYTES; MULTIPLEX POLYMERASE CHAIN REACTION; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE;

EID: 84881158407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070164     Document Type: Article

References (29)

1. Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, et al. (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes 23: 114-119.
2. Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, et al. (2005) Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 192: 46-55.
3. Avettand-Fenoel V, Boufassa F, Galimand J, Meyer L, Rouzioux C, (2008) HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 42: 399-404.
4. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, et al. (2005) Circulating proviral HIV DNA and HIV-associated dementia. Aids 19: 45-52.
5. Shiramizu B, Paul R, Williams A, Shikuma C, Watters M, et al. (2007) HIV proviral DNA associated with decreased neuropsychological function. J Neuropsychiatry Clin Neurosci 19: 157-163.
6. Valcour VG, Shiramizu BT, Shikuma CM, (2010) HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 87: 621-626.
7. Valcour VG, Shiramizu BT, Sithinamsuwan P, Nidhinandana S, Ratto-Kim S, et al. (2009) HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 72: 992-998.
8. Shikuma CM, Nakamoto B, Shiramizu B, Liang CY, DeGruttola V, et al. (2012) Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. Antivir Ther 17: 1233-1242.
9. Glass JD, Fedor H, Wesselingh SL, McArthur JC, (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Annals of neurology 38: 755-762.
10. Bell JE, Brettle RP, Chiswick A, Simmonds P, (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain: a journal of neurology 121 (Pt 11): 2043-2052.
11. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE, (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. Journal of neuropathology and experimental neurology 64: 529-536.
12. Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, et al. (2001) Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184: 699-706.
13. Cantres-Rosario Y, Plaud-Valentin M, Gerena Y, Skolasky RL, Wojna V, et al. (2013) Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders. AIDS 27: 347-356.
14. Sungkanuparph S, Techasathit W, Utaipiboon C, Chasombat S, Bhakeecheep S, et al. (2010) Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomedicine 4: 515-528.
15. Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, et al. (2007) Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection. Neurology 68: 525-527.
16. Maj M, Satz P, Janssen R, Zaudig M, Starace F, et al. (1994) WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51: 51-61.
17. Heaps JM, Valcour V, Chalermchai T, Paul R, Rattanamanee S, et al. (2012) Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. Journal of Clinical and Experimental Neuropsychology In Press.
18. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
19. Shiramizu B, Ananworanich J, Chalermchai T, Siangphoe U, Troelstrup D, et al. (2012) Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy. J Neurovirol 18: 69-73.
20. Schirmer T, Auer DP, (2000) On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 13: 28-36.
21. Wright SM, Wald LL, (1997) Theory and application of array coils in MR spectroscopy. NMR Biomed 10: 394-410.
22. Provencher SW, (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
23. Le Douce V, Herbein G, Rohr O, Schwartz C, (2010) Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7: 32.
24. Gonzalez-Scarano F, Martin-Garcia J, (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
25. Yuan L, Qiao L, Wei F, Yin J, Liu L, et al. (2013) Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol.
26. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, et al. (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America 94: 13193-13197.
27. Alexaki A, Liu Y, Wigdahl B, (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Current HIV research 6: 388-400.
28. Coleman CM, Wu L, (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6: 51.
29. Wirachsilp P, Kantakamalakul W, Foongladda S, Chuenchitra T, Kohriangudom S, et al. (2007) Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand. The Southeast Asian journal of tropical medicine and public health 38: 814-827.